+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Market for Active Pharmaceutical Ingredients in United Kingdom - Forecast and Analysis 2018

  • PDF Icon

    Report

  • 115 Pages
  • June 2019
  • Region: United Kingdom
  • Aruvian Research
  • ID: 4773810

The UK pharmaceutical market is expected to continue with good growth patterns in the coming years. Considered to be very important for the UK economy, the active pharmaceutical ingredient (API) sector of the pharmaceutical industry accounts for nearly 15 percent of the overall European API market, growing at a steady rate in 2017. In the coming years, it is expected that the UK API market will continue to grow at this moderate growth rate with a CAGR of just over 3.5%.

The author analyzes the market for APIs in United Kingdom in its research report Market for Active Pharmaceutical Ingredients in United Kingdom – Forecast and Analysis 2018. The data covered in this report ranges from 2008 till 2020. Let us take a look at what the report focusses on.

The report begins with an introduction to Active Pharmaceutical Ingredients and then moves on to briefly analyze the global market for active pharmaceutical ingredients. We include an overview of the global market for APIs and a look at the global market's revenues.

Section D of the report analyzes the market for active pharmaceutical ingredients in Europe through an industry overview, industry revenues, and a look at the various therapeutic applications of APIs in the European region. Impacts on the European active pharmaceutical ingredients market are also analyzed.

With section E, we begin our analysis of the market for active pharmaceutical ingredients in United Kingdom. This section analyzes the industry through basic statistics and industry revenues. Industry segmentation through the biotech segment and the synthetic API market in United Kingdom is included in the report, along with a forecast of the industry till 2020.

An analysis of the major industry players, both global and domestic, are included in the report. The major players are analyzed through a business segment profile, a look at their major products and services, and a SWOT analysis. The analysis looks at the top companies operating in the UK API market.

Research methodology for the report concludes this comprehensive report on the market for active pharmaceutical ingredients in United Kingdom till 2020.

Table of Contents


A. Executive SummaryB. Introduction to Active Pharmaceutical Ingredients
C. Global Market for Active Pharmaceutical Ingredients (APIs)
C.1 Industry Overview
C.2 Industry Revenues
D. Market for Active Pharmaceutical Ingredients (APIs) in Europe
D.1 Industry Overview
D.2 Industry Revenues
D.3 Therapeutic Applications of API in Europe
D.4 Impacts on the Industry
E. Market for Active Pharmaceutical Ingredients (APIs) in United Kingdom
E.1 Industry Overview
E.2 Industry Revenues
F. API Market in United Kingdom: Industry Segmentation
F.1 Overview
F.2 Biotech API Market in UK
F.3 Synthetic API Market in UK
G. Major Industry Players
G.1 Allergan Plc
G.1.1 Business Profile
G.1.2 Major Products & Services
G.1.3 SWOT Analysis
G.2 BASF SE
G.2.1 Business Profile
G.2.2 Major Products & Services
G.2.3 SWOT Analysis
G.3 Boehringer Ingelheim GmbH
G.3.1 Business Profile
G.3.2 Major Products & Services
G.3.3 SWOT Analysis
G.4 Bristol-Myers Squibb Company
G.4.1 Business Profile
G.4.2 Major Products & Services
G.4.3 SWOT Analysis
G.5 Lonza Group AG
G.5.1 Business Profile
G.5.2 Major Products & Services
G.5.3 SWOT Analysis
G.6 Lupin Limited
G.6.1 Business Profile
G.6.2 Major Products & Services
G.6.3 SWOT Analysis
G.7 Novartis AG
G.7.1 Business Profile
G.7.2 Major Products & Services
G.7.3 SWOT Analysis
G.8 Pfizer Inc.
G.8.1 Business Profile
G.8.2 Major Products & Services
G.8.3 SWOT Analysis
G.9 Teva Pharmaceutical Industries Limited
G.9.1 Business Profile
G.9.2 Major Products & Services
G.9.3 SWOT Analysis
G.10 Cipla Ltd
G.11 Medtronic Plc
G.12 Mylan Inc
G.13 Ranbaxy Laboratories
H. Glossary of TermsI. Research Methodology
List of Figures
Figure 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
Figure 2: Revenues of the Europe Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
Figure 3: Revenue Breakdown of the API Market in Europe by Therapeutic Applications (%), 2017 & 2020
Figure 4: Revenues of the Active Pharmaceutical Ingredient (API) Market in the UK (in USD Million), 2008-2020
Figure 5: UK API Industry Segmentation by Revenues (%), 2008-2020
Figure 6: Revenues of the Biotech API Market in UK by Application Sector (in USD Million), 2008-2020
Figure 7: Share of the Biotech API Market in UK by Application Sector (%), 2008-2020
Figure 8: Revenues of the Synthetic API Market in the UK by Application Sector (in USD Million), 2008-2020
Figure 9: Share of the Synthetic API Market in UK by Application Sector (%), 2008-2020
List of Tables
Table 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
Table 2: Revenues of the Europe Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
Table 3: Revenue Breakdown of the API Market in Europe by Therapeutic Applications (%), 2017 & 2020
Table 4: Pricing & Reimbursement Mechanism in Top Markets in Europe
Table 5: Revenues of the Active Pharmaceutical Ingredient (API) Market in the UK (in USD Million), 2008-2020
Table 6: Revenues of the Biotech API Market in UK by Application Sector (in USD Million), 2008-2020
Table 7: Revenues of the Synthetic API Market in the UK by Application Sector (in USD Million), 2008-2020

Companies Mentioned

  • Allergan Plc
  • BASF SE
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Cipla Ltd
  • Lonza Group AG
  • Lupin Limited
  • Medtronic Plc
  • Mylan Inc
  • Novartis AG
  • Pfizer Inc.
  • Ranbaxy Laboratories
  • Teva Pharmaceutical Industries Limited